|
Hepta
|
Startup
|
|
2022 |
|
|
|
Hi we’re Hepta!
Hepta is a biotechnology company developing an AI-native liquid biopsy platform that decodes epigenetic signals from cell-free DNA using a simple blood sample. Its technology provides tissue-level biological insights without the need for invasive biopsies. The company’s initial focus is on metabolic dysfunction-associated steatohepatitis (MASH), a prevalent liver disease with limited scalable diagnostic options. By combining advanced AI models with cfDNA analysis, Hepta aims to enable earlier detection and routine monitoring of chronic diseases. The platform is designed to reduce diagnostic uncertainty and improve clinical decision-making. Over time, Hepta plans to expand this approach to other chronic and complex diseases.
|
|
Alumni Ventures
|
Investor
|
|
2014 |
|
|
|
Hi we’re Alumni Ventures!
Alumni Ventures is a U.S.-based venture capital firm that invests across early- to late-stage companies in technology-driven sectors such as biotechnology, healthcare, AI, and deep tech. The firm typically backs platforms and businesses that apply advanced technologies such as artificial intelligence, data science, and novel biological approaches—to solve complex real-world problems. Its portfolio spans a wide range of industries, including life sciences, healthtech, enterprise software, and frontier technologies. Alumni Ventures participated in Hepta's seed funding round alongside Illumina Ventures and Felicis Ventures. The investment reflects AV’s focus on AI-enabled healthcare and diagnostics, particularly platforms that can deliver scalable, non-invasive solutions. By backing Hepta, Alumni Ventures is supporting the development of AI-native liquid biopsy technology aimed at improving early detection and monitoring of chronic diseases such as MASH.
|
|
Tata Consultancy Services
|
Industry Player
|
|
1968 |
|
|
|
Hi we’re Tata Consultancy Services!
Tata Consultancy Services is an Indian multinational technology company specializing in information technology services and consulting. They have been actively patenting in synthetic biology with innovations like probiotic supplements, protein coding, therapeutics using gene encoding, CRISPR and Metabolic Engineering technologies.
|
|
Sarvatgc Technologies
|
Startup
|
|
2024 |
Cosmetics
Medical
Food
|
|
|
Hi we’re Sarvatgc Technologies!
Sarvatgc Technologies has developed engineered yeast expression tools such as improved signal peptides, promoters, and optimized constructs, that help yeast secrete recombinant proteins more efficiently, enabling higher-yield production of proteins used in food, nutrition, pharmaceuticals, cosmetics, and other industries.
|
|
Osmania University
|
Academia
|
|
1918 |
|
|
|
Hi we’re Osmania University!
The institute has filed multiple patents on developing probiotics and disease treatment using genetic engineering tools like CRISPR and protein mutations.
|
|
National Institute of Ocean Technology
|
Academia
|
|
1993 |
Cosmetics
Medical
|
|
|
Hi we’re National Institute of Ocean Technology!
The National Institute of Ocean Technology (NIOT) in Chennai has developed a low-cost method to extract ectoine biosynthesis genes from Bacillus clausii and express them in E. coli to produce high amounts of recombinant ectoine for use in skincare, sun protection, and other pharmaceutical applications..
|
|
Andhra University
|
Academia
|
|
1926 |
|
|
|
Hi we’re Andhra University!
The academia has filed couple of patents in synthetic biology for probiotic vaccine and CRlSPR-based diagnostic kit that detects latent HIV-1 infections.
|
|
Avesthagen
|
Industry Player
|
|
2001 |
Medical
Food
Synthetic Biology
|
|
|
Hi we’re Avesthagen!
Avesthagen Limited is an synthetic biology company that uses biology and data science to improve healthcare, working on projects like building a genetic database, studying cancer stem cells, finding useful natural molecules, and developing tools to diagnose and treat infectious diseases.
|
